Cost-effectiveness and budget impact of decentralising childhood tuberculosis diagnosis in six high tuberculosis incidence countries: a mathematical modelling study
Marc d'Elbée,Martin Harker,Nyashadzaishe Mafirakureva,Mastula Nanfuka,Minh Huyen Ton Nu Nguyet,Jean-Voisin Taguebue,Raoul Moh,Celso Khosa,Ayeshatu Mustapha,Juliet Mwanga-Amumpere,Laurence Borand,Sylvie Kwedi Nolna,Eric Komena,Saniata Cumbe,Jacob Mugisha,Naome Natukunda,Tan Eang Mao,Jérôme Wittwer,Antoine Bénard,Tanguy Bernard,Hojoon Sohn,Maryline Bonnet,Eric Wobudeya,Olivier Marcy,Peter J Dodd,TB-Speed Health Economics Study Group,Doris Arlt-Hilares,Eric Balestre,Marie-France Banga,Guillaume Breton,Dim Bunnet,Paul-Damien Chateau,Agathe de Lauzanne,Peter James Dodd,Sanary Kaing,Monica Koroma,Douglas Mbang Masson,Joanna Orne-Gliemann,Eric Ouattara,Julien Poublan,Immaculate Tulinawe,Yara Voss de Lima
DOI: https://doi.org/10.1016/j.eclinm.2024.102528
IF: 15.1
2024-03-21
EClinicalMedicine
Abstract:Background: The burden of childhood tuberculosis remains high globally, largely due to under-diagnosis. Decentralising childhood tuberculosis diagnosis services to lower health system levels could improve case detection, but there is little empirically based evidence on cost-effectiveness or budget impact. Methods: In this mathematical modelling study, we assessed the cost-effectiveness and budget impact of decentralising a comprehensive diagnosis package for childhood tuberculosis to district hospitals (DH-focused) or primary health centres (PHC-focused) compared to standard of care (SOC). The project was conducted in Cambodia, Cameroon, Côte d'Ivoire, Mozambique, Sierra Leone, and Uganda between August 1st, 2018 and September 30th, 2021. A mathematical model was developed to assess the health and economic outcomes of the intervention from a health system perspective. Estimated outcomes were tuberculosis cases, deaths, disability-adjusted life years (DALYs) and incremental cost-effectiveness ratios (ICERs). We also calculated the budget impact of nationwide implementation. The TB-Speed Decentralization study is registered with ClinicalTrials.gov, NCT04038632. Findings: For the DH-focused strategy versus SOC, ICERs ranged between $263 (Cambodia) and $342 (Côte d'Ivoire) per DALY averted. For the PHC-focused strategy versus SOC, ICERs ranged between $477 (Cambodia) and $599 (Côte d'Ivoire) per DALY averted. Results were sensitive to TB prevalence and the discount rate used. The additional costs of implementing the DH-focused strategy ranged between $12.8 M (range 10.8-16.4) (Cambodia) and $50.4 M (36.5-74.4) (Mozambique), and between $13.9 M (12.6-15.6) (Sierra Leone) and $134.6 M (127.1-143.0) (Uganda) for the PHC-focused strategy. Interpretation: The DH-focused strategy may be cost-effective in some countries, depending on the cost-effectiveness threshold used for policy making. Either intervention would require substantial early investment. Funding: Unitaid.